Clinical Trials Browser

Phase 3 × Leukemia, Myeloid, Acute × Aprepitant × Clear all

NCT02979548 2017-01-25

Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute